ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,646Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 324

$524K Total Retail Price of All Prescriptions

Rank: 95 out of 324

391 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 391 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 391 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 10,311 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
AMLODIPINE BESYLATE 510 485 1 4
SIMVASTATIN 477 461 2 1
LEVOTHYROXINE SODIUM 414 394 3 2
OMEPRAZOLE 336 326 4 6
LISINOPRIL 333 309 5 3
POTASSIUM CHLORIDE 301 285 6 8
FUROSEMIDE 241 230 7 7
HYDROCODONE-ACETAMINOPHEN 232 219 S3 8 5
GABAPENTIN 230 218 9 13
METFORMIN HCL 223 213 10 9
PRAVASTATIN SODIUM 208 207 11 21
LOVASTATIN 205 197 12 43
ATORVASTATIN CALCIUM 193 188 13 12
TRAMADOL HCL 188 176 14 19
ALENDRONATE SODIUM 185 185 15 24
METOPROLOL SUCCINATE 172 167 16 17
LOSARTAN POTASSIUM 172 169 16 15
TRIAMTERENE-HCTZ 133 132 18 46
CITALOPRAM HBR 124 121 19 16
ALLOPURINOL 124 114 19 27
ZOLPIDEM TARTRATE 121 121 21 20
ATENOLOL 120 120 22 18
HYDROCHLOROTHIAZIDE 120 108 22 11
WARFARIN SODIUM 119 115 24 10
TAMSULOSIN HCL 118 118 25 26
DONEPEZIL HCL 108 108 26 25
SERTRALINE HCL 102 93 27 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 96 28 35
FLUTICASONE PROPIONATE 93 93 29 32
FENOFIBRATE 93 93 29 79
AMLODIPINE BESYLATE-BENAZEPRIL 89 89 31 100
DIGOXIN 86 82 32 40
MIRTAZAPINE 81 81 33 41
ZETIA 78 78 34 68
GLIMEPIRIDE 77 70 35 37
METOPROLOL TARTRATE 72 68 36 14
NAMENDA 71 71 37 31
AZITHROMYCIN 66 64 38 48
NEXIUM 65 65 39 33
SPIRONOLACTONE 64 64 40 47
EVISTA 62 62 41 116
CRESTOR 59 59 42 28
PANTOPRAZOLE SODIUM 59 59 42 34
SYNTHROID 56 44 44 30
BOOSTRIX 55 54 45 258
ENALAPRIL MALEATE 50 50 46 57
CLOPIDOGREL 50 50 46 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.